Parthenon LLC’s Pfizer PFE Stock Holding History

Parthenon LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Hold	44,962	–	–	0.11%	75
2026 Q1	$1.26M	Sell	44,962 -66	-0.1%	-$1.76K	0.14%	69
2025 Q4	$1.12M	Sell	45,028 -4,752	-10%	-$120K	0.12%	77
2025 Q3	$1.27M	Sell	49,780 -44,244	-47%	-$1.09M	0.14%	74
2025 Q2	$2.28M	Sell	94,024 -2,065	-2%	-$48.2K	0.26%	56
2025 Q1	$2.43M	Hold	96,089	–	–	0.3%	54
2024 Q4	$2.55M	Sell	96,089 -1,513	-2%	-$41K	0.31%	53
2024 Q3	$2.82M	Sell	97,602 -2,550	-3%	-$74.4K	0.34%	54
2024 Q2	$2.8M	Sell	100,152 -5,213	-5%	-$144K	0.36%	51
2024 Q1	$2.92M	Buy	105,365 +783	+0.7%	+$21.7K	0.37%	49
2023 Q4	$3.01M	Sell	104,582 -193	-0.2%	-$5.83K	0.42%	50
2023 Q3	$3.48M	Sell	104,775 -2,538	-2%	-$89.8K	0.52%	42
2023 Q2	$3.94M	Hold	107,313	–	–	0.57%	40
2023 Q1	$4.38M	Sell	107,313 -2,230	-2%	-$96.3K	0.67%	36
2022 Q4	$5.61M	Sell	109,543 -660	-0.6%	-$31.6K	0.92%	33
2022 Q3	$4.82M	Sell	110,203 -254	-0.2%	-$12.3K	0.87%	33
2022 Q2	$5.79M	Sell	110,457 -659	-0.6%	-$33.6K	0.98%	31
2022 Q1	$5.75M	Sell	111,116 -2,000	-2%	-$104K	0.83%	34
2021 Q4	$6.68M	Sell	113,116 -218	-0.2%	-$10.8K	0.94%	33
2021 Q3	$4.87M	Sell	113,334 -4,760	-4%	-$211K	0.73%	34
2021 Q2	$4.63M	Buy	118,094 +4,760	+4%	+$185K	0.69%	36
2021 Q1	$4.11M	Buy	113,334 +1,154	+1%	+$41K	0.66%	37
2020 Q4	$4.13M	Sell	112,180 -7,369	-6%	-$270K	0.71%	36
2020 Q3	$4.16M	Sell	119,549 -421	-0.4%	-$14.8K	0.81%	33
2020 Q2	$3.72M	Hold	119,970	–	–	0.77%	34
2020 Q1	$3.71M	Sell	119,970 -8,959	-7%	-$305K	0.88%	32
2019 Q4	$4.79M	Sell	128,929 -239	-0.2%	-$8.51K	0.96%	30
2019 Q3	$4.4M	Buy	129,168 +358	+0.3%	+$13K	0.94%	31
2019 Q2	$5.29M	Buy	128,810 +1,811	+1%	+$71.9K	1.14%	28
2019 Q1	$5.12M	Sell	126,999 -715	-0.6%	-$28.6K	1.14%	27
2018 Q4	$5.29M	Sell	127,714 -319	-0.2%	-$13.2K	1.3%	24
2018 Q3	$5.35M	Sell	128,033 -3,494	-3%	-$135K	1.18%	29
2018 Q2	$4.53M	Sell	131,527 -5,339	-4%	-$182K	1.04%	34
2018 Q1	$4.61M	Sell	136,866 -963	-0.7%	-$33.1K	1.09%	33
2017 Q4	$4.74M	Buy	137,829 +93	+0.1%	+$3.17K	1.07%	33
2017 Q3	$4.67M	Sell	137,736 -27,373	-17%	-$880K	1.1%	32
2017 Q2	$5.26M	Buy	165,109 +1,619	+1%	+$51.1K	1.25%	27
2017 Q1	$5.31M	Sell	163,490 -2,424	-1%	-$76.4K	1.26%	27
2016 Q4	$5.11M	Buy	165,914 +936	+0.6%	+$28.6K	1.26%	24
2016 Q3	$5.3M	Sell	164,978 -880	-0.5%	-$29.4K	1.32%	24
2016 Q2	$5.54M	Sell	165,858 -285	-0.2%	-$9.1K	1.39%	23
2016 Q1	$4.67M	Buy	166,143 +180	+0.1%	+$5.14K	1.2%	30
2015 Q4	$5.08M	Sell	165,963 -1,671	-1%	-$52.6K	1.33%	24
2015 Q3	$5M	Sell	167,634 -1,619	-1%	-$51.9K	1.39%	25
2015 Q2	$5.38M	Sell	169,253 -307	-0.2%	-$10K	1.42%	24
2015 Q1	$5.6M	Buy	169,560 +923	+0.5%	+$29.3K	1.49%	22
2014 Q4	$4.98M	Sell	168,637 -1,298	-0.8%	-$37.2K	1.37%	24
2014 Q3	$4.77M	Sell	169,935 -122	-0.1%	-$3.42K	1.38%	24
2014 Q2	$4.79M	Sell	170,057 -159	-0.1%	-$4.53K	1.42%	24
2014 Q1	$5.19M	Sell	170,216 -1,891	-1%	-$56.4K	1.56%	22
2013 Q4	$5M	Buy	172,107 +1,660	+1%	+$48.3K	1.53%	20
2013 Q3	$4.64M	Buy	170,447 +5,355	+3%	+$146K	1.54%	21
2013 Q2	$4.39M	Buy	+165,092	New	+$4.56M	1.47%	22

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Parthenon LLC's PFE Position: Q2 2026 in Review

Parthenon LLC held its Pfizer (PFE) position steady in Q2 2026 at 44,962 shares worth $1.08M. The position accounts for 0.11% of the portfolio, ranked #75.

Parthenon LLC first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.68M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Parthenon LLC held 44,962 shares of Pfizer worth $1.08M as of Q2 2026.
Parthenon LLC left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.11% of Parthenon LLC's portfolio in Q2 2026, its #75 holding.
Parthenon LLC first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Parthenon LLC's Pfizer position peaked at $6.68M in Q4 2021.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.